Scarica l'app Stockscreener
16.10
3.94%
-0.66
Precedente Chiudi:
$16.76
Aprire:
$16.07
Volume 24 ore:
94,222
Relative Volume:
0.96
Capitalizzazione di mercato:
$239.17M
Reddito:
Utile/perdita netta:
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
1 W Prestazione:
-7.95%
1M Prestazione:
-50.02%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$15.25
$19.17
Portata 52W:
$12.95
$38.41
Vogenx Inc Common Stock Stock (VOGX) Company Profile
Nome
Vogenx Inc Common Stock
Settore
Industria
Telefono
-
Indirizzo
-
Compare VOGX vs VRTX, MRNA, REGN, ARGX, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VOGX
Vogenx Inc Common Stock
|
16.10 | 239.17M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
Vogenx Inc Common Stock Borsa (VOGX) Ultime notizie
Vogenx Director Peter Pieraccini Granted 50,000 Stock Options at $18.23 Exercise Price - Kalkine Media
155,000 options for Vogenx (VOGX) science chief vest over three years, subject to continued service. - Stock Titan
A director receives 50,000 Vogenx (VOGX) stock options with an $18.23 exercise price. - Stock Titan
Options priced at $18.23 go to Vogenx (VOGX) CFO Steven R. Delmar in a 155,000-option grant. - Stock Titan
Vogenx Director Kenneth John Toombs Submits Initial Form 3 Reporting No Securities Ownership - Kalkine Media
IPO cash gives Vogenx (VOGX) runway amid losses and control weaknesses - Stock Titan
One asset manager group now reports 13% of Vogenx (VOGX) - Stock Titan
Vogenx (VOGX) insiders report 700,000-share stake in new filing - Stock Titan
Vogenx (NASDAQ: VOGX) CFO holds 700K shares plus options - Stock Titan
Vogenx (VOGX) CEO details 1.8M-share stake and option grants - Stock Titan
Vogenx (VOGX) CSO reports options plus 1.8M indirect shares - Stock Titan
Vogenx (VOGX) director holds stock options out to 2036 - Stock Titan
Vogenx (VOGX) director details $0.93–$1.20 stock options - Stock Titan
Vogenx Strengthens Capital Base With IPO Over-Allotment - TipRanks
Jones Served as Sole Book-Running Manager for Vogenx's $81.3 Million Initial Public Offering - PR Newswire
Jones Served as Sole Book-Running Manager for Vogenx's $81.3 Million Initial Public Offering - Nasdaq
Vogenx Announces Closing of Initial Public Offering - Yahoo Finance
Vogenx closes $81.3M IPO at $13 per share, lists on Nasdaq - scanx.trade
Vogenx, Clinical-Stage Biopharmaceutical Developer, Files for NASDAQ IPO - TradingView
Vogenx, Inc. (VOGX) Stock Price, News, Quote & History - Yahoo Finance
Vogenx (VOGX) director reports 26,665 options, 42,735-share note - Stock Titan
VOGX SEC Filings, Aug 12, 2026Vogenx, Inc. Filing Archive - Stock Titan
Vogenx Announces Pricing of Initial Public Offering - Yahoo Finance
Funding Roundup: Braveheart, Attovia, Vogenx All Announce IPO’s - Pharmaceutical Executive
Vogenx, Clinical-Stage Metabolic Disease Therapeutics, Files for Nasdaq Capital Market IPO - TradingView
Vogenx Announces Initial Public Offering Of Common StockSEC Filing - TradingView
Vogenx Inc Common Stock Azioni (VOGX) Dati Finanziari
Non sono disponibili dati finanziari per Vogenx Inc Common Stock (VOGX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):